Suppr超能文献

国家乳腺癌手术辅助治疗项目(协议号4)的病理研究结果。VI. 五年治疗失败的判别因素。

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.

作者信息

Fisher E R, Redmond C, Fisher B

出版信息

Cancer. 1980 Aug 15;46(4 Suppl):908-18. doi: 10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5.

Abstract

Thirty-six pathologic and six clinical characteristics observed in 581 patients enrolled in protocol no. 4 of the National Surgical Adjuvant Breast Project were treated by radical mastectomy and were correlated with five-year treatment failure. The cases were initially stratified according to pathologic nodal status, the most important discriminant in breast cancer. The presence of tumor necrosis, poor tumor differentiation (histologic grade 3) and a tumor size > 4 cm were found by multivariate analyses to influence treatment failure in patients without nodal metastases. Prognosis was usually worse in individuals whose tumors exhibited all of these features than in those in whom only one or two could be detected. Although the sample size was small, life-table analysis also disclosed a highly significant relationship between treatment failure and a germinal center predominance pattern in regional nodes in this subset of patients. Except for this latter, these same discriminants were similarly noted to affect treatment failure in those patients with four or more nodal metastases but not those with only 1--3 positive nodes. A possible explanation for this inconsistency among nodal categories is discussed. Nevertheless, it is concluded that these rather easily measured pathologic parameters represent important discriminants for the prognosis and the design of treatment schemes and subsequent protocols for patients with breast cancer, particularly those without regional nodal metastasis. The findings amplify the importance of intrinsic tumor characteristics as well as possibly host factors in accounting for the clinical behavior of patients with breast cancer.

摘要

对参与国家乳腺癌辅助手术项目4号方案的581例患者观察到的36项病理特征和6项临床特征进行了研究,这些患者均接受了根治性乳房切除术,并与五年治疗失败情况进行了关联分析。病例最初根据病理淋巴结状态进行分层,这是乳腺癌最重要的判别因素。多变量分析发现,肿瘤坏死、肿瘤分化差(组织学3级)以及肿瘤大小>4 cm会影响无淋巴结转移患者的治疗失败情况。肿瘤表现出所有这些特征的个体的预后通常比仅能检测到一两项这些特征的个体更差。尽管样本量较小,但生存表分析也揭示了在这部分患者中,治疗失败与区域淋巴结生发中心优势模式之间存在高度显著的关系。除了后者,同样的判别因素在有四个或更多淋巴结转移的患者中同样被发现会影响治疗失败情况,但在仅有1 - 3个阳性淋巴结的患者中则不然。本文讨论了淋巴结类别之间这种不一致的可能解释。然而,得出的结论是,这些相当容易测量的病理参数是乳腺癌患者预后以及治疗方案和后续方案设计的重要判别因素,尤其是对于那些没有区域淋巴结转移的患者。这些发现进一步强调了肿瘤内在特征以及可能的宿主因素在解释乳腺癌患者临床行为方面的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验